Research And Trials
A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.
In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.
Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.
US scientists have made a handheld device that can distinguish between tumour and healthy tissue in the lab. This could one day help improve cancer surgery.
Scientists at Howard Hughes Medical Institute have developed and shared new mouse models of 12 children’s cancers that could be used to test new drugs.
The majority of e-cigarette experimentation among young people doesn’t turn into regular use, according to a new study.
In this week's cancer news there's vitamin supplements and lung cancer risk, physical activity in middle age and immunotherapy research. Read our digest for more.
Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is.
Scientists have uncovered two potential ways to help the immune system fight cancer better, opening up new avenues for future immunotherapy research.